Publicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (26)

2023

  1. Analysis of the relationship between ambient air pollution and the severity of heart failure decompensations in two Spanish metropolises (Barcelona and Madrid)

    Medicina Clinica, Vol. 161, Núm. 1, pp. 11-19

  2. Antithrombotic Strategy in Secondary Prevention for High-Risk Patients with Previous Acute Coronary Syndrome: Overlap between the PEGASUS Eligibility and the COMPASS Eligibility in a Large Multicenter Registry

    American Journal of Cardiovascular Drugs, Vol. 23, Núm. 1, pp. 77-87

  3. Results in mediastinal lymph node staging of surgical lung cancer: Data from the prospective cohort of the Spanish Video-Assisted Thoracic Surgery Group

    Cirugia Espanola, Vol. 101, Núm. 6, pp. 408-416

2022

  1. Incidence, Clinical Characteristics, Risk Factors and Outcomes of Acute Coronary Syndrome in Patients With COVID-19: Results of the UMC-19-S1010

    Journal of Emergency Medicine, Vol. 62, Núm. 4, pp. 443-454

  2. Ischemic-hemorrhagic balance in diabetic and non-diabetic patients after acute coronary syndrome

    REC: CardioClinics, Vol. 57, Núm. 3, pp. 203-211

2021

  1. Acute heart failure in subtropical climates: Clinical characteristics, management, and outcomes in the canary islands versus continental spain — the canar-ica study results

    Emergencias, Vol. 33, Núm. 6, pp. 413-420

  2. Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets

    The Lancet, Vol. 397, Núm. 10270, pp. 199-207

  3. Ticagrelor or Clopidogrel After an Acute Coronary Syndrome in the Elderly: A Propensity Score Matching Analysis from 16,653 Patients Treated with PCI Included in Two Large Multinational Registries

    Cardiovascular Drugs and Therapy, Vol. 35, Núm. 6, pp. 1171-1182

  4. Ticagrelor versus prasugrel in acute coronary syndrome: sex-specific analysis from the RENAMI Registry

    Minerva cardiology and angiology, Vol. 69, Núm. 4, pp. 408-416

2020

  1. Average daily ischemic versus bleeding risk in patients with ACS undergoing PCI: Insights from the BleeMACS and RENAMI registries

    American Heart Journal, Vol. 220, pp. 108-115

  2. Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelor

    International Journal of Cardiology, Vol. 301, pp. 200-206

  3. Efficacy and Safety of Clopidogrel, Prasugrel and Ticagrelor in ACS Patients Treated with PCI: A Propensity Score Analysis of the RENAMI and BleeMACS Registries

    American Journal of Cardiovascular Drugs, Vol. 20, Núm. 3, pp. 259-269

  4. Identification of Senior At Risk scale predicts 30-day mortality among older patients with acute heart failure

    Medicina Intensiva, Vol. 44, Núm. 1, pp. 9-17

  5. Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: Insights from the RENAMI registry

    European Journal of Preventive Cardiology, Vol. 27, Núm. 7, pp. 696-705

  6. P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects

    European heart journal. Cardiovascular pharmacotherapy, Vol. 6, Núm. 1, pp. 31-42

  7. Time-pattern of adverse outcomes after an infection-triggered acute heart failure decompensation and the influence of early antibiotic administration and hospitalisation: results of the PAPRICA-3 study

    Clinical Research in Cardiology, Vol. 109, Núm. 1, pp. 34-45

2019

  1. Annual Incidence of Confirmed Stent Thrombosis and Clinical Predictors in Patients With ACS Treated With Ticagrelor or Prasugrel

    Revista Espanola de Cardiologia, Vol. 72, Núm. 4, pp. 298-304

  2. Correction to: Real-World Data of Prasugrel vs. Ticagrelor in Acute Myocardial Infarction: Results from the RENAMI Registry (American Journal of Cardiovascular Drugs, (2019), 19, 4, (381-391), 10.1007/s40256-019-00339-3)

    American Journal of Cardiovascular Drugs

  3. Departments involved during the first episode of acute heart failure and subsequent emergency department revisits and rehospitalisations: an outlook through the NOVICA cohort

    European Journal of Heart Failure, Vol. 21, Núm. 10, pp. 1231-1244

  4. Impact of exposure of emergency patients with acute heart failure to atmospheric Saharan desert dust

    Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias, Vol. 31, Núm. 3, pp. 161-166